Latest News

Home testing devices could monitor epilepsy, drug levels, reduce clinical visits

Medications remain the mainstay of epilepsy treatment, and to date there are no FDA-approved devices that provide an accurate means of detection for generalized tonic-clonic seizures (GTCS), or convulsions, during activities of daily living. Two new studies provide data that warrants the development of non-invasive devices with the capability to signal the onset of an epileptic seizure and could be crucial to optimal patient dosing.
View full story

Post your comment.


  • Molecular trigger for cerebral cavernous malformation identified

  • Researchers urge caution in prescribing commonly used drug to treat ADHD

  • Even the elderly can recover from a severe traumatic brain injury

  • Instrument to measure brand embarrassment developed by economists

  • White matter damage caused by 'skunk-like' cannabis, study shows

  • Cognitive behavior therapy can help overcome fear of the dentist

  • How can I tell if they're lying?

  • Amblyopia, not strabismus, identified as key contributor to slow reading in school-age children

  • Visual stress could be a symptom of Chronic Fatigue Syndrome, research suggests

  • Lower availability of omega-3 fatty acids in the body associated with bipolar disorder